// App-Quantinova.ai

POS1250 (2022) : EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY.

Researchers

Presenter

  • . Karakas

Principal Investigators

  • A. Erden

  • B. Armagan

  • S. C. Gven

  • E. Atalar

  • B. Polat

  • A. Omma

  • O. Kksahin

Medical Centers

  • Adana City Hospital, Rheumatology, Adana, Turkey

  • Yildirim Beyazit University, Rheumatology, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A